Tenet Healthcare (NYSE:THC) Stock Rating Lowered by Wall Street Zen

Key Points

• Wall Street Zen downgraded Tenet from "strong-buy" to "buy"; overall the stock has a consensus "Moderate Buy" rating with a mean target price of $250.56 (1 Strong Buy, 18 Buy, 3 Hold).
• Tenet beat quarterly expectations with EPS of $4.70 (vs. $4.08 est.) and $5.53B in revenue, and set FY2026 guidance of 16.19–18.47 EPS (sell-side average ~17.31).
• Company insiders have been net sellers recently, disposing of 46,517 shares worth about $10.94M over the last three months, while insiders retain roughly 0.81% ownership.

Tenet Healthcare (NYSE:THC - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a report released on Saturday.

A number of other analysts also recently weighed in on THC. Guggenheim boosted their target price on Tenet Healthcare from $271.00 to $283.00 and gave the stock a "buy" rating in a research report on Thursday, March 12th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $265.00 price target on shares of Tenet Healthcare in a research note on Monday, February 16th. Morgan Stanley reaffirmed an "overweight" rating and issued a $260.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 12th. KeyCorp lifted their price target on Tenet Healthcare from $225.00 to $250.00 and gave the stock an "overweight" rating in a research note on Thursday, February 12th. Finally, Leerink Partners lifted their price target on Tenet Healthcare from $255.00 to $264.00 and gave the stock an "outperform" rating in a research note on Friday, February 20th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $250.56.

Tenet Healthcare Stock Performance

NYSE:THC opened at $180.72 on Friday. The business has a 50 day moving average of $211.42 and a 200 day moving average of $204.65. The company has a market capitalization of $15.83 billion, a price-to-earnings ratio of 11.67, a PEG ratio of 1.42 and a beta of 1.49. Tenet Healthcare has a 1-year low of $120.74 and a 1-year high of $247.21. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping analysts' consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare's quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, sell-side analysts predict that Tenet Healthcare will post 17.31 earnings per share for the current fiscal year.

Insider Activity

In other news, insider R. Scott Ramsey sold 8,017 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Thomas W. Arnst sold 24,000 shares of the company's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the sale, the executive vice president directly owned 8,012 shares in the company, valued at approximately $1,875,128.48. The trade was a 74.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 46,517 shares of company stock valued at $10,943,111. Company insiders own 0.81% of the company's stock.

Institutional Investors Weigh In On Tenet Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in THC. NewEdge Advisors LLC grew its stake in Tenet Healthcare by 6.1% in the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company's stock worth $389,000 after purchasing an additional 166 shares during the period. Jones Financial Companies Lllp grew its stake in Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company's stock worth $229,000 after purchasing an additional 1,274 shares during the period. Sivia Capital Partners LLC purchased a new stake in Tenet Healthcare in the second quarter worth $290,000. Quantbot Technologies LP purchased a new stake in Tenet Healthcare in the second quarter worth $65,000. Finally, Amundi boosted its holdings in Tenet Healthcare by 4,207.8% in the second quarter. Amundi now owns 27,010 shares of the company's stock worth $4,652,000 after acquiring an additional 26,383 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.